CS Paper Radar

Structured AI ideation yields physical strategies for epithelial barrier repair

Geonho Nah, Johyun Park, Kyung-Ah Cho, Suyoung Hwang, Yoon Hee Lim, Eun-kyung Min, Seunghyun Moon, Donghyun Koh, Seungwon Kim, Jiho Park, Hojin Yoo, Myungsun Nam, Haneul Choi, Kyungsu Kim, In-Sun Hong, YunJae Jung, Minhyeong Lee

cs.AI q-bio.QM ·submitted 2026-11-17 16:05 UTC · v1
unusual

Abstract

AI systems increasingly support literature analysis, candidate evaluation and hypothesis refinement, but enabling researchers to explore research directions beyond established disciplinary approaches remains challenging. We developed Abelio, an AI system designed to generate novel research directions by expanding investigators' avenues of inquiry. Abelio reformulates research objectives, uses these alternative formulations to identify relevant elements outside conventional disciplinary boundaries, and refines the resulting hypotheses. Each stage integrates divergent exploration with convergent selection through a dedicated subsystem. In quantitative evaluations, proposals generated by the Ideation Core (Abelio's hypothesis-generation core) outperformed those of four frontier large language models in scientific soundness and hypothesis diversity, and three of four in distance from existing literature. Subsystem ablation showed that each subsystem contributes to the property it targets, with the contribution of Element Selection measurable before Refinement. To investigate intestinal epithelial barrier restoration, Abelio proposed physical interventions involving membrane-tethered poly(ethylene glycol) (PEG) and cholesterol-anchored complementary DNA. Both proposals were archived before experimentation and subsequently tested independently in damaged Caco-2 monolayers. PEG preserved barrier function in a membrane-surface-dependent manner, whereas complementary DNA enabled sequence-specific restoration that was reversible on demand. These findings demonstrate how structured research ideation can identify experimentally testable approaches beyond established disciplinary conventions.

Closest papers

Nearest neighbours by meaning across the whole index.

Learning Scientific Trajectories to Predict Future Biomedical Discoveries

cs.CL cs.AI ·2026-10-28 ·Chia-Hsuan Chang, Brian Ondov, Jiang Lv, Lan Jiang, Yunmai Wang +5 more
similarity 0.54
Abstract

AI co-scientists have expanded the use of large language models for generating scientific hypotheses and guiding experimental investigation. Here we investigate whether temporal patterns in the semantic representations of complete biomedical conclusions can guide hypothesis generation. We introduce ForeSCITE, a framework that identifies thematic clusters of published conclusions, estimates a direction separating earlier from more recent findings within each cluster, and projects existing conclusion embeddings along these directions. An embedding language model trained to reconstruct conclusions decodes the projected coordinates into natural-language hypotheses. Across 407 clusters derived from approximately three million pre-cutoff conclusions, we identify temporal structure and illustrate its retention after decoding. In retrospective, time-sliced evaluations, ForeSCITE increases semantic coverage beyond the historical corpus, biomedical entity-pair novelty and post-cutoff pair re-observation relative to five prompt-based and retrieval-augmented baselines. Expert review of prioritized CAR-T hypotheses identified 37 candidates as both novel and biologically plausible, and expert justifications for five selected hypotheses illustrate their biological rationale and subsequent literature support where available. These findings support temporal guidance in semantic space as a scalable mechanism for proposing biomedical hypotheses for subsequent scientific evaluation.

0.19

Do Language Models Know What Compelling Scientific Evidence Looks Like?

cs.LG cs.AIcs.CL ·2026-10-29 ·Conor Igoe, Gabriel Grand, Zane Koch, Albert Bou, Eli Moss +4 more
benchmark similarity 0.52
Abstract

Expert scientists excel at weighing empirical findings from multiple sources that vary in both statistical reliability and epistemic relevance. To what extent are language models, which are increasingly driving autonomous discovery systems, capable of such evidence deliberation? We introduce EDB-Bio, a scientific reasoning benchmark curated from real-world data in three biological domains: drug-perturbation transcriptomics, CRISPR screens, and human genome-wide association studies (GWAS). Each of EDB-Bio's 96k episodes presents a sequence of experimental results from published studies and asks the model to predict the probability that a target hypothesis is true. Out-of-the-box, open-weight and frontier models alike demonstrate systematic underconfidence and attain Brier scores comparable to a trivial base-rate forecaster. Post-training against strictly proper scoring rules significantly improves both calibration and discrimination. This calibration pays off downstream: in a sequential experiment selection task, our Ibis0 model is 2.5 times more efficient than the best frontier model. Throughout, quantifying evidence weights as Bayes factors reveals how models update their beliefs over time, whether they agree with expert biologists on relevance, and where they exhibit inconsistencies and biases. Our work extends calibration training and uncertainty analysis to a realistic scientific forecasting setting with applications to human cancer biology. We release all code, data, and trained models.

0.20

Federation Is Nearly Free, Reasoning Is Not: Tradeoffs for AI Co-Scientists in Protein Characterization Workflows

cs.AI cs.MAq-bio.QM ·2026-08-25 ·Maia Kapur, Timothy Boe, Abby Jerger, Paul Rigor
similarity 0.51
Abstract · 24 Pages, 4 main figures, 5 main tables, 2 supplementary figures

Natural language driven autonomous co-scientist workflows involve a fundamental trade-off between flexibility and reasoning at the expense of determinism, reproducibility, and observability. Such agents increasingly must communicate across institutional boundaries, where federation topology can shape latency and cost. We systematically evaluated these tradeoffs using a controlled ablation on a production agentic platform for science. We use a verifiable task: given a protein sequence, we ask an agent to confidently characterize its function by routing across common tools. We compare federation topology, classic RL vs LLM-driven harnesses, language model, and prompt expertise. We also stratify results by protein novelty. We find that the choice of LLM dominated prediction quality far more than topology or prompting (Opus ~92%-94% vs o4-mini ~40%-50%). The PPO policy was nearly as accurate as the best LLM (88%) at zero token cost, fastest latency, and perfect consistency, but yields no reasoning trace. Expert prompted LLMs reached the highest accuracy but were high-cost and less consistent; prompt dependence was largest when the task was hardest. Federation imposed a negligible penalty on performance. These results offer actionable guidance for deploying agents for scientific workflows: for routine, verifiable tasks, a cheap deterministic policy delivers near-frontier accuracy with complete reproducibility, while flexible LLM reasoning is best reserved for open-ended discovery.

0.33

HypoKG: Evidence-Disciplined Biomedical Hypothesis Generation Beyond Endpoint Knowledge

cs.CL cs.AIq-bio.QM ·2026-09-10 ·Dominic Okonkwo, Adetayo Okunoye, Ismailcem Budak Arpinar
top venuebenchmark similarity 0.51
Abstract

Large language models (LLMs) can generate biomedical hypotheses, but it remains unclear whether they truly reason from scientific evidence or simply produce convincing-sounding ideas. To study this, we combine three major biological databases: the Kyoto Encyclopedia of Genes and Genomes (KEGG), Rhea, and UniProt, into a unified biochemical knowledge graph and construct a benchmark of 550 paths connecting enzyme sources to rare disease endpoints, yielding 13,200 hypotheses from six LLMs under four conditions varying the biological information each model receives: source enzyme only, full biological path, or source and disease endpoint only. Hypotheses are scored using an expert-derived five-criterion rubric on a 1-5 scale per criterion. We find that models given both the source and disease endpoint often produce the highest-scoring hypotheses, showing that LLMs can generate compelling ideas from minimal information. However, these hypotheses are less grounded in the evidence. In contrast, models given the full biological path generate hypotheses more consistent with known mechanistic relationships. We call this evidence-disciplined reasoning. To confirm this effect, we shuffled intermediate path steps while keeping endpoints fixed. Evidence grounding dropped significantly (delta = -0.793, p < 0.001), confirming models genuinely used path structure during reasoning. Our findings show that knowledge graphs support hypothesis generation in two ways: they identify biological endpoint pairs absent from the literature, and their mechanistic paths guide how LLMs reason between them.

0.39

Making Sense of Animal-to-Human Drug Development Evidence: Stakeholder Practices, Challenges, and Requirements for AI Tools

cs.HC ·2026-09-30 ·Rosni Vasu, Simona E. Doneva, Benjamin V. Ineichen
similarity 0.51
Abstract · 24 pages, 5 Figures, 12 main pages

Animal models are widely used to study human biology and health interventions, yet translating findings from animal studies to humans remains challenging. Evidence across preclinical and clinical research informs experimental and translational decisions. Artificial Intelligence (AI) tools are increasingly reshaping how this evidence is searched, synthesized, and used, but it remains unclear how they should support the diverse stakeholders involved in assessing animal-to-human evidence. We conducted semi-structured interviews with 13 stakeholders to examine their evidence practices, challenges, and expectations for AI support. We found that stakeholders approach the same incomplete evidence base with different goals, expertise, and heuristics. Participants valued AI particularly for locating, screening, and extracting evidence, but were more cautious about automated interpretation and quality judgments. They emphasized transparency, source traceability, uncertainty communication, and human oversight. Based on these findings, we derive design implications for role-sensitive AI tools that support more systematic and transparent reasoning about animal-to-human translation.

0.18

AI for Biologists: The Knowledge Boundaries of Foundation Models in the Age of Agentic Systems

cs.AI q-bio.BM ·2026-11-12 ·Tian Cai, Andrew Kleist, Jaimin Patel, Duccio Malinverni, Alexander K. Taylor +3 more
similarity 0.51
Abstract · To be published on Annual Review Biomedical Data Science

Artificial intelligence (AI) is changing how biological research is done. Biological foundation models trained on millions of nucleotides, protein, and single-cell measurements predict protein structures, mutation effects, and cellular responses to genetic perturbations. Agentic systems, AI assistants built on large language models, can run multistep analyses from plain-language requests and increasingly call foundation models as tools. Yet it is often unclear when these models' outputs can be trusted. We frame this as a model's knowledge boundary: the range of inputs, tasks, and conditions over which its outputs are reliable. This review explains how foundation models are built and proposes that five design elements (data, architecture, training scheme, evaluation scheme, and post-analysis) define this boundary. We examine evidence on where current models succeed or fail and present standardized descriptions of model limits so that researchers, and the agents acting for them, can use these tools reliably.

0.10

HypoEvolve: Genetic Algorithms Enable Multi-Agent LLMs to Discover Scientific Hypotheses

cs.CL cs.CEcs.MAcs.NE ·2026-09-14 ·Jieyuan Liu, Mengzhou Hu, Jefferson Chen, JungHo Kong, Pratibha Jagannatha +8 more
similarity 0.50
Abstract · 22 pages, 8 figures, 5 tables

Scientific agents contribute to hypothesis discovery by synthesizing evidence, assessing proposals, and developing new explanations. Recent systems combine scientific agents with evolutionary search through critique, comparison, and revision. However, how different forms of agent collaboration affect hypothesis quality remains an open question. Answering this question requires separating the effects of agents' scientific capabilities from those of their collaboration. A framework must therefore preserve agents' scientific roles and support rules for combining, revising, and retaining hypotheses. Building on this view, we introduce HypoEvolve, which makes collaboration explicit through successive updates to a hypothesis population. Specifically, we propose a generational genetic algorithm to coordinate specialized large language model (LLM) agents that integrate mechanistic arguments, reconsider assumptions, and assess evidence and testability. Each generation specifies how scientific judgments and new proposals reshape the population, making collaboration effects on hypothesis quality directly testable. Moreover, we design our evaluation around scientifically meaningful hypotheses that explain how a proposed intervention could work. Drug repurposing links these explanations to target-level biological claims assessed against external evidence. Specifically, we adapt DepMap and Open Targets into complementary external measures grounded in experimental, genetic, and clinical evidence. Across 34 cancer types, HypoEvolve achieves the highest scores against six baselines on both measures. DepMap selectivity reaches 0.171, versus 0.115 for the strongest baseline. Gains over single-pass generation also generalize to held-out cancer types. HypoEvolve advances a vision of autonomous science in which AI research teams achieve a capacity for discovery beyond that of individual models.

0.38

Responsible Integration of AI in Cancer Genomics: Barriers, Risks, and Pathways to Trustworthy Clinical Translation

cs.AI cs.CL ·2026-08-31 ·Bahar İlgen, Yiannos Tolias, Denise Kühnert, Paraskevi Papadopoulou, Magnus Westerlund +3 more
similarity 0.50
Abstract · Review article

Artificial intelligence (AI) and natural language processing (NLP) are increasingly used to extract, integrate, and interpret biomedical knowledge relevant to cancer genomics, yet their translation into routine clinical oncology has been comparatively slow. The central challenge is not computational capability alone, but trustworthy integration into clinical workflows. This review examines how NLP and AI support the cancer genomics pipeline, from literature mining and automated variant interpretation to clinical trial matching, knowledge graph construction, and multimodal data integration. We identify four interrelated translational failure domains: evidence inconsistency, explainability and uncertainty, data governance and reproducibility, and interoperability. Rather than considering these challenges in isolation, we take a systems-level view, focusing on their interaction across the translational pathway. We propose a conceptual framework and roadmap for addressing these domains through rigorous validation, uncertainty-aware methods, interoperable infrastructures, regulatory alignment, and human oversight across the AI lifecycle. Progress toward routine clinical use will depend less on further improving model capability than on systematically addressing these interacting failure domains from development through deployment and post-deployment monitoring.

0.12